Post by
khandaanita4444 on Jul 18, 2022 11:41am
$HEM announced the addition of a wholly owned subsidiary
Hemostemix recently announced the incorporation of PreCerv Inc. (A wholly owned subsidiary of Hemostemix). Hemostemix will grant PreCerv a global field of use licence for NCP-01 and its autologous stem cell technology to treat central and peripheral nervous system diseases.